TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 27776679

Group type: EXPERIMENTAL
Intervention: Quitline services (QL) including a motivational interview, 6 weeks of nicotine patches and gum, a referral to the QL, a booster call, and a quitline brochure.
Number of subjects: 778

Group type: COMPARATOR
Intervention: Control group received only the quitline brochure.
Number of subjects: 778
Study: 24984081

Group type: EXPERIMENTAL
Intervention: Parenteral Nutrition (PN)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Fluid therapy
Number of subjects: 116
Study: 22551742

Group type: EXPERIMENTAL
Intervention: Treatment by a homeopath
Number of subjects: 24
Study: 20202890

Group type: EXPERIMENTAL
Intervention: One-step hydrogen peroxide (H2O2) lens care system (Clear Care)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Multi-purpose disinfecting system (MPDS) (OPTI-FREE RepleniSH)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Both systems (H2O2 and MPDS)
Number of subjects: 26
Study: 17506881

Group type: EXPERIMENTAL
Intervention: Paracheck Pf rapid diagnostic test (RDT)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Artemisinin-based combination therapy (ACT)
Number of subjects: 180
Study: 15703163

Group type: EXPERIMENTAL
Intervention: Gly(16)/Glu(27)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Gly(16)/Gln(27)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Arg(16)/Gln(27)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Brachial intra-arterial propranolol infusion in Gly(16)/Glu(27)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Brachial intra-arterial propranolol infusion in Arg(16)/Gln(27)
Number of subjects: 64
Study: 11174795

Group type: EXPERIMENTAL
Intervention: Upper limb exercise training (n = 26)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Lower limb exercise training (n = 26)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control group (lifestyle advice only, n = 15)
Number of subjects: 52
Study: 9633736

Group type: EXPERIMENTAL
Intervention: High dose intravenous methylprednisolone (IVMP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lower dose intravenous methylprednisolone (IVMP)
Number of subjects: 0
Study: 8164314

Group type: EXPERIMENTAL
Intervention: Sebacate (6.6 g/h)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Sebacate
Number of subjects: 12
Study: 3356852

Group type: COMPARATOR
Intervention: Maternal avoidance of cow's milk and egg during pregnancy
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Maternal intake of cow's milk and egg during lactation
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Minimal cow's milk exposure before 6 months
Number of subjects: 210

Group type: COMPARATOR
Intervention: High levels of maternal IgG, IgA, or IgM antibodies to food at delivery
Number of subjects: 210
Study: 1944900

Group type: EXPERIMENTAL
Intervention: Acetyl-L-carnitine
Number of subjects: 130

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 130
Study: 799559

Group type: EXPERIMENTAL
Intervention: Atenolol (200 mg daily)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 45
Study: 31119578

Group type: EXPERIMENTAL
Intervention: Infected patients
Number of subjects: 466

Group type: EXPERIMENTAL
Intervention: Eosinopenia in infected patients
Number of subjects: 466

Group type: EXPERIMENTAL
Intervention: Deep eosinopenia in infected patients
Number of subjects: 466

Group type: EXPERIMENTAL
Intervention: WBC count modifications with elevated CRP (> 40 mg/L) or fever (> 38.5 °C) in infected patients
Number of subjects: 466

Group type: COMPARATOR
Intervention: Control group of uninfected patients
Number of subjects: 466
Study: 28035663

Group type: EXPERIMENTAL
Intervention: 3-class U-net
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: 2-class U-nets
Number of subjects: 66

Group type: COMPARATOR
Intervention: Atlas-based method
Number of subjects: 66

Group type: COMPARATOR
Intervention: Sheetness-based method
Number of subjects: 66
Study: 26448540

Group type: EXPERIMENTAL
Intervention: Financial incentive of £15 per depot injection over 12 months
Number of subjects: 141

Group type: COMPARATOR
Intervention: Usual health services
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Financial incentive intervention
Number of subjects: 141
Study: 23568049

Group type: EXPERIMENTAL
Intervention: High-volume polyethylene glycol (PEG) 60 mL kg⁻¹ day⁻¹
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Low-volume polyethylene glycol plus bisacodyl (BPEG) 30 mL kg⁻¹ day⁻¹ plus oral bisacodyl 10 to 15 mg/day
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Sennosides 2 mg kg⁻¹ day⁻¹
Number of subjects: 240
Study: 21835301

Group type: EXPERIMENTAL
Intervention: Valsartan
Number of subjects: 1442

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1442
Study: 19349325

Group type: EXPERIMENTAL
Intervention: Ranolazine
Number of subjects: 4918

Group type: EXPERIMENTAL
Intervention: Ranolazine in diabetic patients
Number of subjects: 4918

Group type: EXPERIMENTAL
Intervention: Ranolazine in patients without diabetes
Number of subjects: 4918

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4918
Study: 17074143

Group type: EXPERIMENTAL
Intervention: UPBSCT
Number of subjects: 63

Group type: COMPARATOR
Intervention: UBMT
Number of subjects: 63
Study: 16332607

Group type: EXPERIMENTAL
Intervention: Process-oriented breastfeeding training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Postnatal nurses in the intervention group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Midwives in the intervention group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Midwives in the control group
Number of subjects: 0
Study: 11587253

Group type: EXPERIMENTAL
Intervention: Calcium-fortified milk supplement (3 L weekly in the first year)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Usual diet
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Calcium-fortified milk supplement
Number of subjects: 115
Study: 9623792

Group type: EXPERIMENTAL
Intervention: Wallach Endocell
Number of subjects: 370

Group type: COMPARATOR
Intervention: Vabra
Number of subjects: 370

Group type: EXPERIMENTAL
Intervention: Endocell
Number of subjects: 370
Study: 8162479

Group type: EXPERIMENTAL
Intervention: Active low level laser therapy (LLLT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo laser
Number of subjects: 40
Study: 3144923

Group type: EXPERIMENTAL
Intervention: 15 mg.kg‐1 sodium valproate intravenously over 20 min
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: 2 mg.kg‐1 ketoprofen intravenously over 20 min
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo (5% dextrose)
Number of subjects: 39
Study: 31971045

Group type: EXPERIMENTAL
Intervention: Cognitive behavioural intervention (CBI) for 10 weeks
Number of subjects: 82

Group type: COMPARATOR
Intervention: Usual care control group
Number of subjects: 82
Study: 29961279

Group type: EXPERIMENTAL
Intervention: Actinomycin D (Act‐D)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Floxuridine+Act‐D+vincristine (FAV) or Floxuridine+Act‐D+etoposide+vincristine (FAEV)
Number of subjects: 200

Group type: COMPARATOR
Intervention: EMA/CO or EMA/EP
Number of subjects: 200
Study: 27916783

Group type: EXPERIMENTAL
Intervention: Liraglutide plus insulin
Number of subjects: 17

Group type: COMPARATOR
Intervention: Insulin treatment (control group)
Number of subjects: 17
Study: 25448243

Group type: EXPERIMENTAL
Intervention: Epidural steroid injections (SESIs) - 80mg of triamcinolone in normal saline
Number of subjects: 50

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Epidural steroid injections (SESIs)
Number of subjects: 50
Study: 23795734

Group type: EXPERIMENTAL
Intervention: DPCP sensitization in mountaineers (high altitude)
Number of subjects: 37

Group type: COMPARATOR
Intervention: DPCP sensitization in controls (sea level)
Number of subjects: 37
Study: 21806903

Group type: EXPERIMENTAL
Intervention: Viewing positive images of dentistry (n=35)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Viewing dentally neutral images (n=35)
Number of subjects: 70
Study: 19500693

Group type: EXPERIMENTAL
Intervention: Biochemical response (normal ALT levels)
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Histologic response (reduction of necroinflammation grading by 2 points or more with no increase in fibrosis staging)
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Regression of cirrhosis
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Virologic response (levels of hepatitis B virus DNA below 10,000 copies/mL)
Number of subjects: 195
Study: 16885758

Group type: EXPERIMENTAL
Intervention: Rectal administration of acetaminophen with codeine
Number of subjects: 75

Group type: COMPARATOR
Intervention: Oral administration of acetaminophen with codeine
Number of subjects: 75
Study: 15489842

Group type: EXPERIMENTAL
Intervention: Antihypertensive therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Assessment of cerebral vessels, blood flow, circulatory and metabolic cerebral reserve
Number of subjects: 0
Study: 11451173

Group type: EXPERIMENTAL
Intervention: lamivudine
Number of subjects: 24

Group type: COMPARATOR
Intervention: HBIg
Number of subjects: 24
Study: 9591892

Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 147

Group type: COMPARATOR
Intervention: Atenolol and/or placebo (control)
Number of subjects: 147
Study: 8162673

Group type: EXPERIMENTAL
Intervention: 200 mg ibuprofen
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: 400 mg ibuprofen
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 3139138

Group type: EXPERIMENTAL
Intervention: Intravenous salbutamol (12 micrograms/min continuous infusion for 4 hours)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Nebulised salbutamol (5 mg nebulised on admission, plus two more 5 mg doses at 30 minutes and 2 hours)
Number of subjects: 76
Study: 31404750

Group type: EXPERIMENTAL
Intervention: Continuous flow (CF)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Demand oxygen delivery system based on liquid oxygen (DODS-DL)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Demand oxygen delivery system oxygen concentrator (DODS-DC)
Number of subjects: 70
Study: 26302885

Group type: EXPERIMENTAL
Intervention: 8% CHO mouth rinse (MR)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 6% CHO ingestion (ING)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 6
Study: 26480544

Group type: EXPERIMENTAL
Intervention: Warm acupuncture combined with auricular acupuncture
Number of subjects: 130

Group type: COMPARATOR
Intervention: Simple warm acupuncture
Number of subjects: 130
Study: 22107250

Group type: EXPERIMENTAL
Intervention: High carbohydrate and whey protein diet (HCP)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Normal diet (CON)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: SIM60 (simulated match for 60 minutes)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: SIM90 (simulated match for 90 minutes)
Number of subjects: 16
Study: 21745627

Group type: EXPERIMENTAL
Intervention: Small rice particles (500-1000 μm)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Large rice particles (>2000 μm)
Number of subjects: 0
Study: 18823713

Group type: EXPERIMENTAL
Intervention: Stranded seeds (SS)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Loose seeds (LS)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Stranded seeds (SS) and Loose seeds (LS)
Number of subjects: 20
Study: 16959472

Group type: EXPERIMENTAL
Intervention: ondansetron (8 mg/day) combined with haloperidol (4-30 mg/day)
Number of subjects: 121

Group type: COMPARATOR
Intervention: placebo combined with haloperidol (4-30 mg/day)
Number of subjects: 121
Study: 14752676

Group type: EXPERIMENTAL
Intervention: Normal saline with added potassium (NS)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Polyethylene glycol (PG)
Number of subjects: 54
Study: 10786387

Group type: EXPERIMENTAL
Intervention: Loratadine/pseudoephedrine sulfate
Number of subjects: 20
Study: 9348566

Group type: EXPERIMENTAL
Intervention: MMC/UFT (20 mg of MMC sprinkled on the operating field, 6 mg/m2 of MMC intravenously on day 7 and monthly for 6 months, 400 mg/day of UFT orally for 1 year)
Number of subjects: 834

Group type: COMPARATOR
Intervention: Surgery only (control group)
Number of subjects: 834

Group type: EXPERIMENTAL
Intervention: MMC/UFT
Number of subjects: 834
Study: 1316914

Group type: EXPERIMENTAL
Intervention: Percoll preparation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Swim-up preparation
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study: 3916444

Group type: EXPERIMENTAL
Intervention: Behavioural approach with extensive counselling by experienced dietitians (n = 99)
Number of subjects: 178

Group type: COMPARATOR
Intervention: No continuous dietary advice (Control group, n = 79)
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: Subgroups with and without sodium reduction
Number of subjects: 178
Study: 29659016

Group type: EXPERIMENTAL
Intervention: Full attention condition (incidental encoding)
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Divided attention condition (incidental encoding)
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Full attention condition (intentional encoding)
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Divided attention condition (intentional encoding)
Number of subjects: 186
Study: 29923136

Group type: EXPERIMENTAL
Intervention: Geospatial risk assessment system using SEPA topsoil data
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Geospatial risk assessment system using SGU biogeochemical data
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Geospatial risk assessment system using SGU geophysical data
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Fuzzy classification for risk assessment
Number of subjects: 173
Study: 25524052

Group type: EXPERIMENTAL
Intervention: TV-1380
Number of subjects: 0
Study: 23837430

Group type: EXPERIMENTAL
Intervention: Written handover cognitive aid
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard practice
Number of subjects: 20
Study: 23028596

Group type: EXPERIMENTAL
Intervention: Pre-meal protein drinks (PMPD) containing whey protein isolates (9 g protein)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Pre-meal protein drinks (PMPD) containing soy protein isolates (9 g protein)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Pre-meal protein drinks (PMPD) with added amino acids (iso, leu, lys, thr, val)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Pre-meal protein drinks (PMPD) with added amino acids + arg
Number of subjects: 14

Group type: COMPARATOR
Intervention: Reference meal (water provided 250 ml)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Pre-meal protein drinks (PMPD)
Number of subjects: 14
Study: 19776051

Group type: EXPERIMENTAL
Intervention: Niacinamide (250 mg twice daily, titrated to 750 mg twice daily)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15

Group type: COMPARATOR
Intervention: Niacinamide vs Placebo
Number of subjects: 15
Study: 17451408

Group type: EXPERIMENTAL
Intervention: Bortezomib
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dexamethasone
Number of subjects: 0
Study: 15000754

Group type: EXPERIMENTAL
Intervention: Hypothermia
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Gender (female)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Gender effect
Number of subjects: 68
Study: 15515533

Group type: EXPERIMENTAL
Intervention: Indirect laryngoscope (IL)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Direct laryngoscope (DL)
Number of subjects: 23
Study: 10813237

Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unfractionated heparin
Number of subjects: 0
Study: 10073836

Group type: EXPERIMENTAL
Intervention: Candesartan cilexetil 16 mg once daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Candesartan cilexetil 32 mg once daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 2071085

Group type: EXPERIMENTAL
Intervention: Nisoldipine 10 mg/day
Number of subjects: 24

Group type: COMPARATOR
Intervention: Diltiazem 3 x 60 mg/day
Number of subjects: 24
Study: 6404238

Group type: EXPERIMENTAL
Intervention: Cefoxitin sodium (n = 51)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Placebo (saline, n = 52)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Cost analysis with prophylactic antibiotics
Number of subjects: 103
Study: 31504709

Group type: EXPERIMENTAL
Intervention: Whole grain wheat (WGW) consumption (98 g/d) for 12 weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: Refined wheat (RW) consumption
Number of subjects: 50
Study: 30292535

Group type: EXPERIMENTAL
Intervention: Psychological counseling for 40 minutes with professional counselors
Number of subjects: 34

Group type: COMPARATOR
Intervention: Chatting for 40 minutes with professional counselors
Number of subjects: 34
Study: 26423328

Group type: EXPERIMENTAL
Intervention: Mop handle height at shoulder level
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Mop handle height at chin level
Number of subjects: 13

Group type: COMPARATOR
Intervention: Mop handle height at eye level
Number of subjects: 13
Study: 25025992

Group type: EXPERIMENTAL
Intervention: Pioglitazone 15-30 mg/day added on calcium channel blockers (CCBs)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Calcium channel blockers (CCBs) alone
Number of subjects: 73
Study: 22328206

Group type: EXPERIMENTAL
Intervention: ABT-594 150 μg
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: ABT-594 225 μg
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: ABT-594 300 μg
Number of subjects: 266

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: ABT-594 (all doses)
Number of subjects: 266
Study: 21111985

Group type: EXPERIMENTAL
Intervention: Model 1 (clinical factors + neurohormones)
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Model 2 (NT‐proBNP only)
Number of subjects: 190
Study: 18845954

Group type: EXPERIMENTAL
Intervention: Community mobilization, mobile voluntary counseling and testing (VCT), and posttest support services
Number of subjects: 14657

Group type: EXPERIMENTAL
Intervention: Unprotected intercourse in the previous 6 months
Number of subjects: 14657
Study: 15975459

Group type: EXPERIMENTAL
Intervention: Trypan blue 1%
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Indocyanine green 0.5%
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control without stain
Number of subjects: 46
Study: 12756571

Group type: EXPERIMENTAL
Intervention: ECC (180 degrees s(‐1))
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: ECC (30 degrees s(‐1))
Number of subjects: 24

Group type: COMPARATOR
Intervention: CON
Number of subjects: 24
Study: 10211504

Group type: EXPERIMENTAL
Intervention: Total pelvic floor repair
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Gluteus maximus transposition
Number of subjects: 24
Study: 7985367

Group type: EXPERIMENTAL
Intervention: Magnetic resonance angiography (MR angiography)
Number of subjects: 48
Study: 2735330

Group type: EXPERIMENTAL
Intervention: sucralfate 2 g twice daily for six weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ranitidine 300 mg at bedtime
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: pentagastrin 0.1 and 6.0 micrograms/kg/hour or histamine acid phosphate 4.0 and 40 micrograms/kg/hour (secretory stimulants)
Number of subjects: 0
Study: 1097221

Group type: EXPERIMENTAL
Intervention: Loxapine succinate
Number of subjects: 50

Group type: COMPARATOR
Intervention: Chlorpromazine
Number of subjects: 50
Study: 30479044

Group type: EXPERIMENTAL
Intervention: Silymarin 1% gel
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 28436572

Group type: EXPERIMENTAL
Intervention: 1200 mg delayed-release cysteamine bitartrate
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96
Study: 25900350

Group type: EXPERIMENTAL
Intervention: Levodopa (100 mg administered at each session for five sessions over 1 week)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (administered at each session for five sessions over 1 week)
Number of subjects: 0
Study: 22555988

Group type: EXPERIMENTAL
Intervention: Training-only group (34 carers)
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Training-plus-screening protocol group (35 carers)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Wait-list control group (38 carers)
Number of subjects: 107
Study: 19949165

Group type: EXPERIMENTAL
Intervention: Donepezil (10 mg)
Number of subjects: 145

Group type: COMPARATOR
Intervention: Placebo followed by Donepezil (10 mg)
Number of subjects: 145
Study: 18248656

Group type: EXPERIMENTAL
Intervention: Lubiprostone 16 microg b.d.
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Lubiprostone 32 microg b.d.
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Lubiprostone 48 microg b.d.
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Lubiprostone (all doses)
Number of subjects: 195

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 195
Study: 16803749

Group type: EXPERIMENTAL
Intervention: Body‐Mind‐Spirit (BMS) intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Supportive‐Expressive (SE) intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Social Support Self‐Help (SS) intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 0
Study: 12950856

Group type: EXPERIMENTAL
Intervention: Ketoprofen lysine salt (OKi) suppositories
Number of subjects: 85

Group type: COMPARATOR
Intervention: Paracetamol
Number of subjects: 85
Study: 11063410

Group type: EXPERIMENTAL
Intervention: Maintenance engineers (exposed group)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Computer programmers (controls)
Number of subjects: 31
Study: 8726291

Group type: EXPERIMENTAL
Intervention: Various interventions in gastroenterology
Number of subjects: 200
Study: 1303113

Group type: EXPERIMENTAL
Intervention: 1% chlorhexidine gel delivered with toothpicks
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 7
Study: 3891033

Group type: EXPERIMENTAL
Intervention: Physostigmine (60 micrograms X kg‐1)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Physostigmine
Number of subjects: 15